What's new in IDIS:

 • New Drugs

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Continuing Education Articles

 • Priority Clinical Practice Guidelines

 

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

IDIS Logo   IDIS Monthly Update Information - August 2013

NEW DRUG TERM
B2G1 DELTA NAB
BMS-986001
BNO-101
DUPILUMAB
ECTOINE
ESBA-105
FICLATUZUMAB
GLYCEROL PHENYLBUTYRATE
GSK-2251052
LAMBROLIZUMAB
LUTEOLIN
MK-3641
NOX-A-12
SURINABANT
TP-3805, CU 64
VRS-317

CODE
82000010
8180830
92510299
82000583
84060031
82000821
10120310
40100009
8122959
82000584
88320006
80164004
14000092
92000398
36680133
68280033



DRUG NAME/CODE CHANGES

OLD TERM & CODE
BAY-632521 24120079

NEW TERM & CODE
RIOCIGUAT 24120079


FDA APPROVAL PACKAGES

Article Numbers 701223-701238: Radium Ra 223 Dichloride Injection, Xofigo, FDA Approval Package for NDA 203971. FDA Approval Package 2013.

Article Numbers 701034-701049: Dabrafenib Mesylate, Tafinlar, FDA Approval Package for NDA 202806. FDA Approval Package 2013.

Article Numbers 701018-701033: Trametinib, Mekinist Tablets, FDA Approval Package for NDA 204114. FDA Approval Package 2013.


CONTINUING EDUCATION ARTICLES

Article Number 701941: Anonymous. Crofelemer (Fulyzaq) for Antiretroviral-Induced Diarrhea (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 701939-701941]. Med Lett Drugs Ther 2013, 55:59-60.

Article Number 701940: Anonymous. Citalopram, Escitalopram and the QT Interval (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 701939-701941]. Med Lett Drugs Ther 2013, 55:59.

Article Number 701939: Anonymous. Brinzolamide/Brimonidine (Simbrinza) for Glaucoma (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 701939-701941]. Med Lett Drugs Ther 2013, 55:57-58.

Article Number 701933: Cada D J, Levien T L, Baker D E. Alogliptin (0.15 CEU). Hosp Pharm 2013, 48:580-592.

Article Number 701220: Anonymous. Ospemifene (Osphena) for Dyspareunia (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 701218-701220]. Med Lett Drugs Ther 2013, 55:55-56.

Article Number 701219: Anonymous. Quartette: An Ascending-Dose, Extended-Cycle Oral Contraceptive (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 701218-701220]. Med Lett Drugs Ther 2013, 55:54-55.

Article Number 701218: Anonymous. Kcentra: A 4-Factor Prothrombin Complex Concentrate for Reversal of Warfarin Anticoagulation (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 701218-701220]. Med Lett Drugs Ther 2013, 55:53-54.

Article Number 701216: Anonymous. Tobramycin Inhalation Powder (Tobi Podhaler) for Cystic Fibrosis (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 701214-701216]. Med Lett Drugs Ther 2013, 55:51-52.

Article Number 701215: Anonymous. Nutritional Supplements for Age-Related Macular Degeneration Revisited (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 701214-701216]. Med Lett Drugs Ther 2013, 55:50-51.

Article Number 701214: Anonymous. Liptruzet: A Combination of Ezetimibe and Atorvastatin (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 701214-701216]. Med Lett Drugs Ther 2013, 55:49-50.

Article Number 700810: Cada D J, Levien T L, Baker D E. Apixaban (0.15 CEU). Hosp Pharm 2013, 48:494-509.

Article Number 700795: Cada D J, Demaris K, Levien T L, Baker D E. Tofacitinib (0.15 CEU). Hosp Pharm 2013, 48:413-424.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 701221: Anonymous. Full Guideline. Myocardial Infarction with ST-Segment Elevation: The Acute Management of Myocardial Infarction with ST-Segment Elevation. NICE Clinical Guideline No. 167 (Ref Art 701222). NICE Clin Guidel 2013.


College of Pharmacy